SENTÍ CLAPÉS, Mariano

SENTÍ, M.; ELOSUA, R.; TOMÁS, M.; SALA, J.; MASIÀ, R.; ORDOVÁS, J. M.; MARRUGAT, J., for the REGICOR Investigators (..., Covas, M. I.; Fitó, M.; Gil, M.; Pena, A., ...). Physical activity modulates the combined effect of a common variant of the lipoprotein lipase gene and smoking on serum triglyceride levels and high-density lipoprotein cholesterol in men. Hum Genet, 109. 2001. Pàg. 385-392.

SENTÍ, M.; TOMÁS, M.; VILA, J. S.; MARRUGAT, J.; ELOSUA, R.; SALA, J.; MASIÀ, R. Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study. Atherosclerosis, 156. 2001. Pàg. 443-449.

TOMÁS, M.; ELOSUA, R.; SENTÍ, M.; MOLINA, L.; VILA, J. S.; ANGLADA, R.; FITÓ, M.; COVAS, M. I.; MARRUGAT, J. Paraoxonase1-192 polymorphism modulates the effects of regular and acute exercise on paraoxonase1 activity. J Lipid Res, 43. 2002. Pàg. 713-720.

TOMÁS, M.; SENTÍ, M.; ELOSUA, R.; VILA, J. S.; SALA, J.; MASIÀ, R.; MARRUGAT, J. Interaction between the G1n-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity. Eur J Pharmacol, 432. 2001. Pàg. 121-128.

VALVERDE CASTRO, Miguel Ángel

DÍAZ, M.; BAHAMONDE, M. I.; LOCK, H.; MUÑOZ-LÓPEZ, F. J.; HARDY, S. P.; POSAS, F.; VALVERDE, M. A. Okadaic acid-sensitive activation of Maxi Cl- channels by triphenylethylene antioestrogens in C1300 mouse neuroblastoma cells. J Physiol (Lond), 536. 2001. Pàg. 79-88.

MUÑOZ-LÓPEZ, F. J.; OPAZO, C.; GIL-GÓMEZ, G.; TAPIA, G.; FERNÁNDEZ, V.; VALVERDE, M. A.; INESTROSA, N. C. Vitamin E but not 17ß-estradiol protect against vascular toxicity induced by ß-amyloid wild type and the Dutch amyloid variant. J Neurosci 2002. 22(8):3081-9.

NADAL, A.; DÍAZ, M.; VALVERDE, M. A. The estrogen trinity: membrane, cytosolic, and nuclear effects. News Physiol Sci, 16. 2001. Pàg. 251-255.

VALVERDE, M. A. Realidades y retos de las nuevas tecnologías. A: VILA CASAS, A. (ed.). Opinión Quiral: Sostenibilidad del Sistema Sanitario. Barcelona: Rubes Editorial, 2001. Pàg. 78-83.

VALVERDE, M. A.; HARDY, S. P.; DÍAZ, M. Activation of Maxi Cl-chanels by antiestrogens and phenotiazines in NIH3T3 fibroblasts. 2002. Steroids 67(6). Pàg. 439-445.

VALVERDE, M. A.; PARKER, M. G. Classical and novel seroid actions: a unified but complex view. Trends in Biochemical Sciences. 2002. 27 (4). Pàg. 172-173.

VALVERDE GRANADOS, Olga
MACCARRONE, M.; VALVERDE, O.; BARBACCIA, M. L.; CASTAÑÉ, A.; MALDONADO, R.; LEDENT, C.; PARMENTIER, M.; FINAZZI-AGRÒ, A. Age-related changes of anandamide metabolism in CB₁ cannabinoid receptor knockout mice: correlation with behaviour. Eur J Neurosci, 15. 2002. Pàg. 1178-1186.

NAVARRO, M.; CARRERA, M. R. A.; FRATTA, W.; VALVERDE, O.; COSSU, G.; FATTORE, L.; CHOWEN, J. A.; GÓMEZ, R.; DEL ARCO, I.; VILLANÚA, M. A.; MALDONADO, R.; KOOB, G. F.; RODRÍGUEZ DE FONSECA, F. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci, 21. 2001. Pàg. 5344-5350.

ZIMMER, A.; VALJENT, E.; KÖNIG, M.; ZIMMER, A. M.; ROBLEDO, P.; HAHN, H.; VALVERDE, O.; MALDONADO, R. Absence of delta-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. J Neurosci, 21. 2001. Pàg. 9499-9505.

MARTÍN-SÁNCHEZ, M.; LEDENT, C.; PARMENTIER, M.; MALDONADO, R.; VALVERDE, O. Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl), 159. 2002. Pàg. 379-387.